Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Aug 7, 2026, 5:51 PM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 10.55 million as of August 10, 2026. Its market cap has decreased by -18.75% in one year.
Market Cap
10.55M
Enterprise Value
-6.36M
Revenue
474.83K
Ranking
n/a
PE Ratio
0.81
Stock Price
0.07
ChartMarket Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 10.55M, a decrease of -74.86%. That is a compound annual growth rate of -25.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 10.55M | -27.78% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | 41.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzai Health | 22.77M |
| Devonian Health Group | 21.55M |
| Pharmala Biotech Holdings | 15.29M |
| Hemostemix | 13.85M |
| Rapid Dose Therapeutics | 12.28M |
| PreveCeutical Medical | 12.24M |
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 9.62M |